The Community Guide

- gsearch

Search Results

Narrow Results:

2015 1
2014 1
2012 1

ENGAGE Consortium Telomere Group 1

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk

CITE Title : Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk Personal Author(s) : Walsh, Kyle M.;Codd, Veryan;Smirnov, Ivan V.;Rice, Terri;Decker, Paul A.;Hansen, Helen M.;Kollmeyer, Thomas;Kosel, Matthew L.;Molinaro, Annette M.;McCoy, Lucie S.;Bracci, Paige M.;Cabriga, Belinda S.;Pekmezci, Melike;Zheng, Shichun;Wiemels, Joseph L.;Pico, Alexander R.;Tihan, Tarik;Berger, Mitchell S.;Chang, Susan M.;Prados, Michael D.;Lachance, Daniel H.;O’Neill, Brian P.;Sicotte, Hugues;Eckel-Passow, Jeanette E.;van der Harst, Pim;Wiencke, John K.;Samani, Nilesh J.;Jenkins, Robert B.;Wrensch, Margaret R.; Corporate Authors(s) : ENGAGE Consortium Telomere Group Published Date : 7 2014;7-2014; Source : Nat Genet. 46(7):731-735 URL : https://stacks.cdc.gov/view/cdc/27881 Walsh, Kyle M. et al. (2014). Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. 46(7). Walsh, Kyle M. et al. "Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk" 46, no. 7 (2014) Walsh, Kyle M. et al. "Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk" vol. 46, no. 7, 2014 Export RIS Citation Information.

:

Walsh, Kyle M. ;

Codd, Veryan

7 2014 | Nat Genet. 46(7):731-735

:

Glioma, the most common central nervous system cancer in adults, has poor prognosis. Here we identify a new SNP associated with glioma risk, rs1920116...
SSBP2 variants are associated with survival in glioblastoma patients

CITE Title : SSBP2 variants are associated with survival in glioblastoma patients Personal Author(s) : Xiao, Yuanyuan;Decker, Paul A.;Rice, Terri;McCoy, Lucie S.;Smirnov, Ivan;Patoka, Joseph S.;Hansen, Helen M.;Wiemels, Joe L.;Tihan, Tarik;Prados, Michael D.;Chang, Susan M.;Berger, Mitchel S.;Kosel, Matthew L.;Fridley, Brooke L.;Lachance, Daniel H.;O’Neill, Brian Patrick;Buckner, Jan C.;Thompson, Reid C.;Nabors, L. B.;Olson, Jeffrey J.;Brem, Steve;Madden, Melissa H.;Browning, James E.;Wiencke, John K.;Egan, Kathleen M.;Jenkins, Robert B.;Wrensch, Margaret R.; Published Date : 6 1 2012;6-1-; Source : Clin Cancer Res. 18(11):3154-3162 URL : https://stacks.cdc.gov/view/cdc/33534 Xiao, Yuanyuan et al. (2012). SSBP2 variants are associated with survival in glioblastoma patients. 18(11). Xiao, Yuanyuan et al. "SSBP2 variants are associated with survival in glioblastoma patients" 18, no. 11 (2012) Xiao, Yuanyuan et al. "SSBP2 variants are associated with survival in glioblastoma patients" vol. 18, no. 11, 2012 Export RIS Citation Information.

:

Xiao, Yuanyuan ;

Decker, Paul A.

6 1 2012 | Clin Cancer Res. 18(11):3154-3162

:

PurposeGlioblastoma is a devastating, incurable disease with few known prognostic factors. Here we present the first genome-wide survival and validati...
Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time

CITE Title : Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time Personal Author(s) : Zhou, Mi;Bracci, Paige M.;McCoy, Lucie S.;Hsuang, George;Wiemels, Joseph L.;Rice, Terri;Zheng, Shichun;Kelsey, Karl T.;Wrensch, Margaret R.;Wiencke, John K.; Published Date : 8 15 2015;8-15-; Source : Int J Cancer. 137(4):826-836 URL : https://stacks.cdc.gov/view/cdc/32967 Zhou, Mi et al. (2015). Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. 137(4). Zhou, Mi et al. "Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time" 137, no. 4 (2015) Zhou, Mi et al. "Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time" vol. 137, no. 4, 2015 Export RIS Citation Information.

:

Zhou, Mi ;

Bracci, Paige M.

8 15 2015 | Int J Cancer. 137(4):826-836

:

Defects in antigen presenting cell function have been implicated in glioma immunosuppression. We measured peripheral CCL22, a dendritic cell/macrophag...